Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ability to support current customers, expand its customer base and enter new markets such as Canada and Australia, where it earned regulatory approvals within the last year, Steve Deitsch, CFO of Organox, told BioWorld.
Berlin Heals Holding AG recently raised over CHF7 million (US$7.8 million) in a financing round for C-MIC, a small implantable device it believes can reverse heart failure.
Med-tech firms raising money in public or private financings, including: Boston Scientific, Firefly Neuroscience Inc., Organox, Pavmed, Sonar, Veris Health.
EG 427 SAS has closed a €27 million (US$28.3 million) series B round, which will fund it to completion of the first clinical trial of the lead gene therapy program, opening the way for its herpes simplex viral-vectored products to be developed in a range of chronic neuro-urology disorders.
Med-tech firms raising money in public or private financings, including: Anbio Biotechnology Ltd., Approxima Srl, Atrandi Biosciences, Level Zero Health., Valencia Technologies, Vitalconnect Inc.
RSS
